Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Arizona Oncology - Tucson

(FURMO-004) A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

  • Details

ClinicalTrials.gov ID: NCT05607550
Diagnosis Type: Lung Cancer
USOR Number: 22198

  • Practice Details

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Prescott Valley

(FURMO-004) A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

  • Details

ClinicalTrials.gov ID: NCT05607550
Diagnosis Type: Lung Cancer
USOR Number: 22198

  • Practice Details

3188 N. Windsong Dr., Suite A
Prescott Valley, AZ 86314
P: (928) 775-9430

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)(D926XC00001)

  • Details

ClinicalTrials.gov ID: NCT05629585
Diagnosis Type: Breast Cancer
USOR Number: 22187

  • Practice Details

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)(D926XC00001)

  • Details

ClinicalTrials.gov ID: NCT05629585
Diagnosis Type: Breast Cancer
USOR Number: 22187

  • Practice Details

1620 W. St. Mary's Rd.
Tucson, AZ 85745
P: (520) 624-7445

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)(D926XC00001)

  • Details

ClinicalTrials.gov ID: NCT05629585
Diagnosis Type: Breast Cancer
USOR Number: 22187

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)(D926XC00001)

  • Details

ClinicalTrials.gov ID: NCT05629585
Diagnosis Type: Breast Cancer
USOR Number: 22187

  • Practice Details

1845 W. Orange Grove, Bldg. 2
Tucson, AZ 85704
P: (520) 624-7445

More Details View Practice Page

Breast Cancer

Clinical Trial at: Arizona Oncology - Goodyear

A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Who Have Residual Invasive Disease in the Breast and/or Axillary Lymph Nodes at Surgical Resection Following Neoadjuvant Systemic Therapy (TROPION-Breast03)(D926XC00001)

  • Details

ClinicalTrials.gov ID: NCT05629585
Diagnosis Type: Breast Cancer
USOR Number: 22187

  • Practice Details

13555 W. McDowell Rd.
Suite 105
Goodyear, AZ 85395
P: (623) 469-4222

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung) Substudy-01: Patients With No Prior Systemic Treatment for Metastatic NSCLC (GS-US-624-6376-01)

  • Details

ClinicalTrials.gov ID: NCT05633667
Diagnosis Type: Lung Cancer
USOR Number: 22181

  • Practice Details

1845 W. Orange Grove, Bldg. 2
Tucson, AZ 85704
P: (520) 624-7445

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung) Substudy-01: Patients With No Prior Systemic Treatment for Metastatic NSCLC (GS-US-624-6376-01)

  • Details

ClinicalTrials.gov ID: NCT05633667
Diagnosis Type: Lung Cancer
USOR Number: 22181

  • Practice Details

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Phase 2 Platform Study Evaluating the Safety and Efficacy of Novel Treatment Combinations in Patients With Lung Cancer (VELOCITY-Lung) Substudy-01: Patients With No Prior Systemic Treatment for Metastatic NSCLC (GS-US-624-6376-01)

  • Details

ClinicalTrials.gov ID: NCT05633667
Diagnosis Type: Lung Cancer
USOR Number: 22181

  • Practice Details

1620 W. St. Mary's Rd.
Tucson, AZ 85745
P: (520) 624-7445

More Details View Practice Page
1 2 3 4 … 13

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.